Deerfield Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.5M | Sell |
2,879,476
-542,673
| -16% | -$11.8M | 1.13% | 23 |
|
|
2025
Q1 | $83M | Buy |
3,422,149
+289,138
| +9% | +$7.01M | 1.64% | 20 |
|
|
2024
Q4 | $65.4M | Sell |
3,133,011
-3,096,623
| -50% | -$64.6M | 1.24% | 23 |
|
|
2024
Q3 | $124M | Sell |
6,229,634
-2,897,671
| -32% | -$57.6M | 1.85% | 13 |
|
|
2024
Q2 | $141M | Sell |
9,127,305
-3,512
| -0% | -$54.4K | 2.35% | 9 |
|
|
2024
Q1 | $146M | Buy |
9,130,817
+241,916
| +3% | +$3.86M | 2.53% | 7 |
|
|
2023
Q4 | $149M | Buy |
8,888,901
+696,901
| +9% | +$11.7M | 2.76% | 6 |
|
|
2023
Q3 | $95.8M | Hold |
8,192,000
| – | – | 2.11% | 15 |
|
|
2023
Q2 | $110M | Sell |
8,192,000
-2,163,099
| -21% | -$29.1M | 2.35% | 11 |
|
|
2023
Q1 | $172M | Buy |
10,355,099
+4,470,651
| +76% | +$74.1M | 3.83% | 4 |
|
|
2022
Q4 | $109M | Buy |
5,884,448
+988,448
| +20% | +$18.4M | 2.27% | 11 |
|
|
2022
Q3 | $62.8M | Buy |
+4,896,000
| New | +$62.8M | 1.25% | 26 |
|